NCT07248696 2025-11-25
Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial
Chongqing University Cancer Hospital
Phase NA Active not recruiting
Chongqing University Cancer Hospital
Affiliated Hospital of Nantong University